Heron Therapeutics, Inc.

HRTX XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

85M

Short interest (May 15)

21.0%

Net Short (Jun 03 ): 1.2%

Borrow Fee

0.74%

↓ 5.5%

Available Shares

900K

↓ 57.0%

Price Chart

Company Overview

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0000818033
Asset Type: CS

Market Data

Market Cap: $85,175,716
Employees: 122
Status: Active

Short Interest

Current Borrow Fee 0.74%
Range: 0.62% - 0.74%
Available Shares 900K
Range: 150K - 1M

Recent Changes

Fee Change: ↑ 9.4%
Available Change: ↓ 64.7%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime